Dextera Surgical Inc. said it does not intend to appeal Nasdaq's determination that it is not in compliance with the minimum $2.5 million stockholders' equity requirement for continued listing.

As a result, the company expects trading in its stock to be suspended on Oct. 26, and for the stock to be removed from listing and registration on Nasdaq.

The company decided not to submit an appeal due to the amount of the stockholders' deficit, the prospects for regaining compliance and the cost of the appeals process.

Dextera said it has applied to the OTC Markets Group for a listing of its common stock on the OTCQB venture market.